Taketani et al. reported that the DR5 gene is a direct target of ATF3 upon DNA damage, and ATF3 plays a key role in apoptosis induced by camptothecin (CPT) /TRAIL co-treatment of human colorectal cancer cells (90). The gene discussed is TNFSF10; the disease is colorectal cancer.